JW (Cayman) Therapeutics Co. Ltd (JWCTF)
USD 0.17
(0.0%)
USD 0.17
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -789.6 Million CNY | 7.74% |
| 2022 | -855.88 Million CNY | -12.75% |
| 2021 | -759.08 Million CNY | -72.19% |
| 2020 | -440.83 Million CNY | -115.38% |
| 2019 | -204.68 Million CNY | -82.37% |
| 2018 | -112.23 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -17.02 Million USD | 0.0% |
| 2024 Q1 | -17.13 Million USD | 53.77% |
| 2023 Q4 | -37.07 Million USD | -106.94% |
| 2023 FY | -789.6 Million CNY | 7.74% |
| 2023 Q3 | -17.91 Million USD | 60.02% |
| 2023 Q2 | -44.8 Million USD | -99.48% |
| 2023 Q1 | -22.46 Million USD | 57.91% |
| 2022 Q4 | -53.37 Million USD | -113.15% |
| 2022 FY | -855.88 Million CNY | -12.75% |
| 2022 Q2 | -53.55 Million USD | 0.0% |
| 2022 Q3 | -25.03 Million USD | 53.25% |
| 2021 Q4 | -68.41 Million USD | 0.0% |
| 2021 Q2 | -52.03 Million USD | 0.0% |
| 2021 FY | -759.08 Million CNY | -72.19% |
| 2020 Q4 | -39.98 Million USD | 0.0% |
| 2020 FY | -440.83 Million CNY | -115.38% |
| 2020 Q2 | -23.24 Million USD | 0.0% |
| 2019 FY | -204.68 Million CNY | -82.37% |
| 2019 Q4 | -18.45 Million USD | 0.0% |
| 2019 Q2 | -11.8 Million USD | 0.0% |
| 2018 FY | -112.23 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | -999.946% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 16165.867% |
| SQZ Biotechnologies Company | -75.82 Million USD | -941.354% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -4324.312% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 1064.678% |
| Mesoblast Limited | -84.14 Million USD | -838.366% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -51305.066% |
| Genus plc | 6.4 Million USD | 12437.609% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 8204.802% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -84678.179% |
| Marizyme, Inc. | -34.08 Million USD | -2216.479% |
| ContraFect Corporation | -56.88 Million USD | -1287.978% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -9356.371% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -17235.993% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -56220.404% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -27600.581% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -28604.224% |
| MultiCell Technologies, Inc. | -722.81 USD | -109241194.393% |
| Accustem Sciences Inc. | -3.74 Million USD | -20976.313% |
| RVL Pharmaceuticals plc | -58.99 Million USD | -1238.544% |
| EV Biologics, Inc. | -483.06 Thousand USD | -163358.728% |
| Q BioMed Inc. | -3.44 Million USD | -22816.28% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 22405.282% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -202586.809% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -29951.394% |
| Biomind Labs Inc. | -1 Million USD | -78109.653% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | -16081.983% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -11777.335% |
| Skye Bioscience, Inc. | -13.67 Million USD | -5675.443% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -39649.074% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -2636141.319% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -15552.883% |
| IMV Inc. | -38.67 Million USD | -1941.831% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -4875.552% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -40757.028% |
| GB Sciences, Inc. | -1.42 Million USD | -55486.202% |
| Alpha Cognition Inc. | -9.7 Million USD | -8035.581% |
| HST Global, Inc. | -140.9 Thousand USD | -560274.573% |
| CSL Limited | 3.7 Billion USD | 121.329% |
| Halberd Corporation | -75.05 Thousand USD | -1052007.928% |
| Enzolytics Inc. | -2.14 Million USD | -36646.417% |
| Resverlogix Corp. | -12.74 Million USD | -6093.482% |
| Affymax, Inc. | -15.04 Million USD | -5147.953% |
| SYBLEU INC | -149.18 Thousand USD | -529198.163% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -24822.308% |
| argenx SE | -425.04 Million USD | -85.768% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -1322.51% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -75532.854% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -49895.536% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -23089.776% |
| AVAX Technologies, Inc. | 6.69 Million USD | 11897.716% |
| Zenith Capital Corp. | -8.94 Million USD | -8729.33% |
| Genscript Biotech Corporation | -415.79 Million USD | -89.905% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -4532401.005% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -32059.065% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -460286.635% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -1336.371% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -27116.097% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -80140.292% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -42252.484% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -62766.799% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -39286.669% |
| BioStem Technologies, Inc. | -7.77 Million USD | -10050.535% |
| ONE Bio Corp. | 13.68 Million USD | 5871.328% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -434981.136% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -59027.503% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -70093.154% |
| Agentix Corp. | -1.37 Million USD | -57461.768% |
| LadRx Corporation | -3.82 Million USD | -20550.738% |
| Cell Source, Inc. | -4.32 Million USD | -18155.349% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -189947.391% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -114843.882% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -114843.882% |
| NovAccess Global Inc. | -2.46 Million USD | -31909.883% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -26946.486% |
| Itoco Inc. | -919.14 Thousand USD | -85807.152% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -18529.775% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -70463.628% |
| Kadimastem Ltd | -3.04 Million USD | -25871.779% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -301592.228% |
| CytoDyn Inc. | -18.05 Million USD | -4272.616% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -3136995.749% |
| Mobile Lads Corp. | -554.55 Thousand USD | -142286.98% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -358685.067% |
| Qrons Inc. | -643.67 Thousand USD | -122571.309% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -139722.001% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -35310.307% |
| Rebus Holdings, Inc. | -664 Thousand USD | -118816.717% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -43372.901% |
| International Stem Cell Corporation | -663 Thousand USD | -118996.078% |
| Bioxytran, Inc. | -3.82 Million USD | -20569.545% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -1499913.298% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -3881940.315% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -2077.265% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -48701.422% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -107207.617% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -25281.131% |
| Neutra Corp. | -229.48 Thousand USD | -343976.327% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -4402.007% |
| PureTech Health plc | -146.19 Million USD | -440.091% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -3574.108% |
| IXICO plc | -1.43 Million USD | -54848.295% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -8219.534% |
| Gelesis Holdings, Inc. | -121.8 Million USD | -548.25% |
| CSL Limited | 3.81 Billion USD | 120.714% |
| Cellectis S.A. | -108.85 Million USD | -625.359% |